Hai Long Yu | Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

Best Researcher Award

Hai Long Yu
Researcher Hai Long Yu
Affiliation Universiti Sains Malaysia
Country Malaysia
Scopus ID 58881245200
Documents 2
Citations 12
h-index 1
Subject Area Pharmacology
Event Global Scholar Awards
ORCID 0000-0002-2639-9780

Hai Long Yu
Universiti Sains Malaysia

Hai Long Yu is affiliated with Universiti Sains Malaysia and conducts research within the field of pharmacology. The available scholarly record indicates contributions emphasizing pharmaceutical science and related biomedical investigations. Through peer-reviewed publications indexed by Scopus, the researcher has established an emerging academic profile that demonstrates commitment to evidence-based research, scientific integrity, and interdisciplinary collaboration within modern pharmaceutical research environments.[1]

Abstract

Hai Long Yu has developed an emerging research profile in pharmacology through scholarly publications addressing pharmaceutical science, biomedical investigation, and evidence-based therapeutic research. The available literature demonstrates attention to scientific methodology, analytical rigor, and collaborative academic practices supporting advances in healthcare knowledge. Published work contributes to understanding pharmacological mechanisms and pharmaceutical applications while strengthening interdisciplinary scientific communication. Citation performance reflects growing recognition within the academic community. These contributions collectively illustrate sustained engagement with high-quality research activities and support professional consideration for academic recognition through the Best Researcher Award.[1][2]

Keywords

Pharmacology, pharmaceutical sciences, drug development, biomedical research, therapeutic compounds, molecular pharmacology, pharmaceutical analysis, experimental medicine, clinical translation, evidence-based therapeutics.

Introduction

Hai Long Yu conducts pharmacological research emphasizing scientific investigation, pharmaceutical innovation, and biomedical relevance. Current scholarly outputs demonstrate careful experimental methodology supporting improved understanding of therapeutic compounds, pharmaceutical applications, and healthcare advancement while contributing valuable knowledge through internationally indexed publications and collaborative academic research activities.[1]

Research Profile

Hai Long Yu maintains a developing scholarly profile at Universiti Sains Malaysia with publications indexed in Scopus. Research metrics demonstrate emerging academic influence supported by peer-reviewed outputs, measurable citation performance, interdisciplinary collaboration, and continuing participation in pharmaceutical research addressing scientifically significant biomedical questions.[1]

Research Contributions

Hai Long Yu contributes to pharmacological knowledge through research integrating experimental evaluation, pharmaceutical science, and biomedical interpretation. Published findings improve understanding of therapeutic mechanisms while encouraging scientific collaboration, reproducibility, and evidence-based decision making within pharmaceutical investigations and related healthcare research disciplines.[2]

Publications

Hai Long Yu has published peer-reviewed research indexed within Scopus, reflecting contributions to pharmacology and pharmaceutical science. Available publications demonstrate methodological consistency, scientific reporting standards, and collaborative investigation while supporting broader dissemination of biomedical knowledge through internationally recognized academic publishing platforms.[1][3]

Research Impact

Hai Long Yu demonstrates measurable scholarly impact through citations, peer-reviewed publications, and international indexing. Research visibility supports knowledge dissemination, encourages scientific collaboration, and provides foundational evidence benefiting pharmaceutical investigations while strengthening recognition within the broader pharmacology research community.[1]

Award Suitability

Hai Long Yu demonstrates qualities supporting consideration for the Best Researcher Award through emerging publication performance, scientific integrity, interdisciplinary collaboration, and measurable research visibility. Continued contributions to pharmacology align with recognition emphasizing innovation, academic excellence, and sustained commitment to evidence-based scientific advancement.[4]

Conclusion

Hai Long Yu continues developing an academic portfolio characterized by pharmacological research, peer-reviewed publications, and collaborative scientific inquiry. Available scholarly achievements demonstrate meaningful progress toward broader research influence while supporting continued professional recognition through international academic awards and future pharmaceutical research contributions.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Hai Long Yu, Author ID 58881245200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58881245200
  2. ORCID. (n.d.). Research profile of Hai Long Yu.
    https://orcid.org/0009-0008-0390-3308
  3. ResearchGate. (n.d.). Hai Long YuΒ research profile and scholarly outputs.
    https://www.researchgate.net/profile/Yu-Hai-Long
  4. Global Scholar Awards. (n.d.). Best Researcher Award Information.
    https://globalscholarawards.com/

Xiaoguang Huang | Pharmacology | Innovative Research Award

Published on by Global Scholar Awards

Innovative Research Award

Xiaoguang Huang
Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd, China

Xiaoguang Huang
Affiliation Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd
Country China
Scopus ID 57221178957
Documents 3
Citations 2
h-index 1
Subject Area Pharmacology
Event Global Scholar Awards
Scopus View Profile

Xiaoguang Huang is affiliated with Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd in China and contributes to research activities within Pharmacology. His academic profile demonstrates participation in scientific publications, citation visibility, and pharmaceutical research engagement. These scholarly activities support recognition within the Global Scholar Awards and reflect continued involvement in pharmacological and healthcare-related scientific advancement.[1]

Abstract

Xiaoguang Huang has contributed to pharmacological research through scholarly publications and scientific participation within pharmaceutical studies. His academic profile reflects publication visibility, citation activity, and engagement in healthcare-related scientific communication. The available research metrics demonstrate developing academic influence and commitment to pharmaceutical research advancement. His scholarly contributions support recognition within the Global Scholar Awards framework and indicate ongoing participation in evidence-based pharmacological investigations. The combination of publication records, institutional affiliation, and scientific engagement highlights his contribution to Pharmacology and supports broader academic dissemination within pharmaceutical and healthcare research communities internationally.[1]

Keywords

  • Pharmacology
  • Pharmaceutical Research
  • Drug Development
  • Healthcare Innovation
  • Scientific Publications
  • Global Scholar Awards

Introduction

Academic recognition within pharmaceutical sciences reflects research participation, scientific communication, and contribution to healthcare advancement. Xiaoguang Huang has engaged in Pharmacology research through publication activities and scholarly participation. His academic visibility and citation metrics support recognition within internationally focused pharmaceutical and scientific award programs.[1]

Research Profile

Xiaoguang Huang is affiliated with Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd in China and maintains scholarly visibility through Scopus-indexed publications and citation-based research metrics. His documented academic profile includes scientific publications, citation records, and measurable participation in pharmaceutical and healthcare-related scholarly communication activities.[1]

Research Contributions

His research contributions demonstrate engagement in pharmacological investigations and pharmaceutical research activities. Through scholarly publications and scientific participation, he has contributed to healthcare-related knowledge dissemination and academic communication. These efforts support broader scientific discussion and encourage continued advancement within pharmaceutical research communities internationally.[2]

Publications

The publication record associated with Xiaoguang Huang demonstrates participation in scientific dissemination and pharmacological research communication. His indexed academic outputs contribute to research accessibility, citation visibility, and institutional representation while supporting scholarly engagement through peer-reviewed scientific and pharmaceutical publication activities.[1]

Research Impact

Citation performance and publication visibility indicate measurable scholarly participation within pharmacological research. These academic indicators demonstrate engagement in scientific communication and healthcare knowledge development. The available research metrics reflect ongoing contribution to pharmaceutical scholarship and support recognition of continued academic involvement.[1]

Award Suitability

Xiaoguang Huang’s research profile, scholarly publications, and pharmaceutical research participation align with the objectives of the Global Scholar Awards. His academic visibility, citation activity, and scientific engagement demonstrate qualities associated with recognition programs focused on research excellence, healthcare advancement, and scholarly contribution.[3]

Conclusion

The academic activities of Xiaoguang Huang reflect scholarly participation within Pharmacology through scientific publications, citation visibility, and pharmaceutical research engagement. His developing research profile and institutional contributions support recognition within academic award frameworks dedicated to healthcare innovation, scientific communication, and pharmaceutical research advancement.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Xiaoguang Huang, Author ID 57221178957. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57221178957
  2. Global Scholar Awards. (n.d.). International academic recognition and research excellence program.
    Global Scholar Awards
  3. Huang, X., Zhang, A., Chen, D., Jia, Z., & Li, X. (2026). 4-Substituted 4-(1H-1,2,3-triazol-1-yl)piperidine: Novel C7 moieties of fluoroquinolones as antibacterial agents. SSRN Electronic Journal.
    https://pubmed.ncbi.nlm.nih.gov/20347299/

Patrick Blin | Pharmacology | Research Excellence Award

Published on by Global Scholar Awards

Dr. Patrick Blin | Pharmacology | Research Excellence Award

University of Bordeaux | France

Dr. Patrick Blin is a distinguished researcher at UniversitΓ© de Bordeaux, recognized for his significant contributions to pharmacoepidemiology, clinical research, and real-world evidence studies. With an impressive record of 133 publications, 3,897 citations, and an h-index of 29, his work demonstrates substantial scientific impact and global recognition. His research focuses on drug safety, cardiovascular diseases, diabetes, and healthcare outcomes, often utilizing large-scale national healthcare databases. He has collaborated extensively with a wide network of international researchers, enhancing the interdisciplinary scope of his work. His studies contribute to improving clinical decision-making, optimizing therapeutic strategies, and advancing public health policies, thereby delivering meaningful societal and healthcare impact.

Citation Metrics (Scopus)

3897
3000
2000
1000
0

Citations

3897

Documents

133

h-index

29

Citations

Documents

h-index

View Scopus Profile View ORCID Profile View ResearchGate Profile

Featured Publications

Mahmoud Mansour | Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

Prof. Mahmoud Mansour | Pharmacology | Best Researcher Award

Professor | King Saud bin Abdulaziz University for Health Sciences | Saudi Arabia

Dr. Mahmoud Ahmed Mansour is a biomedical researcher affiliated with King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia, with recognized expertise in biochemical toxicology, oxidative stress, pharmacology, and cancer biology. His research primarily focuses on the molecular mechanisms of hepatocarcinogenesis, proteasome inhibition, antioxidant defense systems, and cardiometabolic complications. Dr. Mansour has authored 40 peer-reviewed publications, accumulating over 1,879 citations, with an h-index of 18, reflecting sustained scientific impact and scholarly influence. His highly cited works explore the antineoplastic potential of proteasome inhibitors such as carfilzomib, as well as oxidative stress in metabolic and reproductive health conditions. He has collaborated with more than 50 international co-authors, demonstrating strong interdisciplinary and cross-institutional engagement. The societal relevance of his research lies in advancing therapeutic strategies for cancer prevention, metabolic disorders, and drug-induced toxicity, contributing to improved clinical understanding and translational biomedical outcomes at a global level.

Citation Metrics (Scopus)

1879
1400
900
400
0

Citations

1,879

Documents

40

h-index

18

Citations

Documents

h-index

View Google Scholar Profile View Scopus Profile View ORCID Profile

Featured Publications

Mohsen Mehrabi | Pharmacology | Excellence in Academic-Industry Collaboration Award

Published on by Global Scholar Awards

Assist. Prof. Dr.Mohsen Mehrabi | Pharmacology | Excellence in Academic-Industry Collaboration Award

Assistant Professor of Medical Nanotechnology atΒ Shahroud University of Medical Sciences, Iran

Dr. Mohsen Mehrabi is an Assistant Professor of Medical Nanotechnology at Shahroud University of Medical Sciences, with a Ph.D. in Medical Nanotechnology from Tehran University of Medical Sciences. His research focuses on drug and vaccine delivery systems, nanoparticles for wound healing, and nanofiber-based wound dressings. He has published extensively in high-impact journals, contributing significantly to biomedical advancements, particularly in chitosan-based vaccine delivery, essential oil nanoemulsions, and cancer therapies. With expertise in polymeric nanoparticles, niosomes, and phytosomes, his work bridges fundamental research and practical medical applications. Additionally, he holds an MBA in Strategic Management, enhancing his ability to lead interdisciplinary projects. Despite his strong academic record, increased international collaborations, patents, and industry partnerships could further amplify his impact. Dr. Mehrabi’s dedication to innovation in nanomedicine and consistent research output make him a strong candidate for the Best Researcher Award, recognizing his contributions to advancing medical sciences

Professional ProfileΒ 

Education

Dr. Mohsen Mehrabi has a diverse and multidisciplinary educational background in medical sciences and nanotechnology. He earned his Ph.D. in Medical Nanotechnology from the School of Advanced Medical Technology at Tehran University of Medical Sciences (2012-2018), where he specialized in nanoparticle-based vaccine delivery systems. Prior to that, he completed his M.Sc. in Medical Nanotechnology at the same institution (2008-2011), focusing on chitosan nanoparticles for drug delivery. He also pursued an MBA in Strategic Management at Tehran University (2021-2022), enhancing his expertise in research leadership and project management. His undergraduate education includes a B.Sc. in Medical Laboratory Sciences from Jondi Shapour Medical University of Ahvaz (2005-2007) and an Associate Degree in Medical Laboratory Sciences from Shiraz University of Medical Sciences (2001-2003). His strong academic foundation in nanomedicine, biotechnology, and medical sciences has significantly contributed to his research in drug delivery, vaccine development, and biomedical applications.

Professional Experience

Dr. Mohsen Mehrabi is an Assistant Professor of Medical Nanotechnology at the School of Medicine, Shahroud University of Medical Sciences (2018–present). With expertise in nanomedicine, drug delivery systems, and biomedical applications, he has played a key role in advancing research on nanoparticle-based drug and vaccine delivery, wound healing, and cancer therapies. His professional journey includes extensive academic research, supervision of scientific projects, and collaboration with international experts in the field of nanotechnology. His work on polymeric nanoparticles, niosomes, phytosomes, and hydrogel-based wound dressings has led to multiple high-impact publications. Additionally, his MBA in Strategic Management has equipped him with leadership and project management skills, allowing him to contribute to research strategy and innovation. Dr. Mehrabi’s dedication to interdisciplinary research and translational science has positioned him as a leading figure in medical nanotechnology, making significant contributions to both academic and applied biomedical research.

Research Interest

Dr. Mohsen Mehrabi’s research interests focus on nanotechnology-driven solutions for drug and vaccine delivery, wound healing, and biomedical applications. His work primarily explores polymeric nanoparticles (chitosan and alginate), niosomes, and phytosomes for targeted drug and vaccine delivery systems, aiming to enhance therapeutic efficacy and immunogenicity. He is particularly interested in the development of nanoparticle-based vaccine carriers, including chitosan-loaded recombinant hepatitis B antigen, to improve immune response. His research extends to essential oil nanoemulsions for antimicrobial and therapeutic applications in both human and veterinary medicine. Additionally, he investigates hydrogel-based nanoparticles for wound healing and nanofiber mesh as advanced wound dressings. His interdisciplinary approach integrates nanomedicine, biotechnology, and pharmaceutical sciences to develop innovative and efficient drug delivery systems. Through his work, Dr. Mehrabi aims to bridge the gap between fundamental nanoscience and clinical applications, contributing to advancements in precision medicine and targeted therapies.

Award and Honor

There is no specific information provided about awards and honors received by Dr. Mohsen Mehrabi. However, given his significant contributions to the field of medical nanotechnology, his extensive research on drug and vaccine delivery systems, and his numerous high-impact publications, he is a strong candidate for academic recognition and prestigious research awards. His work on chitosan-based nanoparticles, essential oil nanoemulsions, and hydrogel-based wound dressings has advanced biomedical applications, making a notable impact in nanomedicine and biotechnology. Additionally, his leadership in interdisciplinary research and his role as an Assistant Professor at Shahroud University of Medical Sciences further highlight his academic excellence. While specific accolades are not listed, his dedication, innovation, and contributions to medical sciences make him a potential recipient of awards recognizing excellence in nanotechnology, drug delivery, and vaccine research. Further details on awards and honors could strengthen his professional profile.

Research Skill

Dr. Mohsen Mehrabi possesses advanced research skills in medical nanotechnology, drug delivery systems, and biomedical applications. His expertise includes the design, synthesis, and characterization of polymeric nanoparticles such as chitosan, alginate, niosomes, and phytosomes for targeted drug and vaccine delivery. He has extensive experience in nanoparticle formulation, stability assessment, and in vitro/in vivo evaluation of drug-loaded systems. His skills extend to hydrogel-based wound dressings, nanofiber mesh fabrication, and essential oil nanoemulsions for therapeutic applications. He is proficient in physicochemical characterization techniques, including spectroscopy, electron microscopy, and chromatographic methods, to analyze nanoparticle properties and drug release profiles. His ability to integrate nanotechnology, immunology, and pharmaceutical sciences enables him to develop novel therapeutic strategies. Additionally, his strategic research planning and project management skills, supported by his MBA in Strategic Management, enhance his ability to lead interdisciplinary studies and contribute to cutting-edge innovations in nanomedicine.

Conclusion

Dr. Mohsen Mehrabi has a remarkable research record in nanomedicine and drug delivery, making him a strong contender for the Best Researcher Award. His work has significant scientific merit, real-world medical applications, and global relevance. Strengthening industry collaborations, patenting innovations, and increasing international leadership roles could further solidify his candidacy.

Publications Top Noted

  1. Title: Comparison of the protective effects of CS/TPP and CS/HPMCP nanoparticles containing berberine in ethanol-induced hepatotoxicity in rat

    • Authors: Mahboubi Kancha M., Alizadeh M., Mehrabi M.
    • Year: 2024
    • Citation: 2

  2. Title: Isolation and Characterization of Extracellular Vesicles of Chick Embryo Blood

    • Authors: Rezakhania L., Gharibshahian M., Zamani S., Mehrabi M., Alizadeh M.
    • Year: 2024
    • Citation: 1

 

 

You said:
Craft compelling and forward-looking web content for the ‘Pharmacology’ Begin with a very short introduction and very short

Wirginia KrzyΕ›ciak | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award

Published on by Global Scholar Awards

Dr. Wirginia KrzyΕ›ciak | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award

Acting Head of Department of Medical Diagnostics at the Faculty of Pharmacy of the Medical College of the Jagiellonian University in Krakow, PolandΒ 

Dr. Wirginia KrzyΕ›ciak is a distinguished researcher and academic leader in the field of medical diagnostics, currently serving as the Acting Head of the Department of Medical Diagnostics at the Jagiellonian University Medical College (JU MC) in Poland. With a career spanning over a decade, she has made significant contributions to the study of schizophrenia, clinical biochemistry, and the relationship between oral microbiota and brain function 🧠. A prolific author with 85 original scientific papers and a strong h-index of 16, Dr. KrzyΕ›ciak’s work is highly regarded in both national and international academic circles 🌍. She also serves on the editorial boards of several high-impact scientific journals, focusing on biostatistics, brain diseases, and biomolecules related to biofilm diseases. Beyond her research, she is actively involved in mentoring, having supervised numerous master’s and doctoral theses πŸŽ“.

Professional profile

EducationπŸ“š

Dr. Wirginia KrzyΕ›ciak has a rich academic background rooted in the medical and pharmaceutical sciences. She earned her Doctoral Degree in Medical Sciences, specializing in clinical biochemistry from Jagiellonian University Medical College (JU MC) in 2009 πŸŽ“. In 2018, she achieved her habilitation in Pharmaceutical Science, a prestigious qualification marking her academic excellence and expertise. Dr. KrzyΕ›ciak’s education has laid a strong foundation for her research endeavors in schizophrenia and clinical diagnostics. She has also contributed to academic literature, authoring numerous papers and chapters in textbooks πŸ“š. Her academic qualifications are further bolstered by her active membership in several scientific societies, including the Polish Microbiology Society and the Polish Biochemistry Society. Through her education, Dr. KrzyΕ›ciak has gained deep insights into the biochemical and molecular aspects of schizophrenia, positioning her as a leading researcher in her field πŸ”¬.

Professional ExperienceπŸ›οΈ

Dr. Wirginia KrzyΕ›ciak has over a decade of professional experience in the fields of medical diagnostics and clinical biochemistry. Since 2010, she has held various academic positions at Jagiellonian University Medical College (JU MC), starting as an Assistant and later becoming an Adjunct in the Department of Medical Diagnostics πŸ§‘β€πŸ”¬. She is currently the Acting Head of the Department, where she leads cutting-edge research on schizophrenia and biomolecular diagnostics. Beyond her academic role, Dr. KrzyΕ›ciak is an expert consultant for the Central Medical Laboratory in Bytom πŸ₯. Her leadership extends to numerous research projects, including those focused on oral microbiota and brain function. Dr. KrzyΕ›ciak is also deeply involved in mentoring, having supervised 25 master’s theses and two doctoral dissertations πŸŽ“. Her comprehensive experience in research, diagnostics, and teaching makes her a key figure in the field of clinical biochemistry and pharmaceutical sciences.

Research Interest🌐

Dr. Wirginia KrzyΕ›ciak’s research interests are centered on the intersection of clinical biochemistry, medical diagnostics, and neuroscience 🧠. She has made significant contributions to understanding the biochemical and molecular underpinnings of schizophrenia, focusing on the relationship between oral microbiota and brain function, oxidative stress, and metabolic imbalances πŸ§ͺ. Her recent projects explore innovative diagnostic biomarkers, particularly in brain diseases and biofilm-related infections, which hold promise for personalized medical approaches. Additionally, Dr. KrzyΕ›ciak is intrigued by the role of acid stress in central nervous system disorders and the potential therapeutic interventions targeting these pathways. As the principal investigator in multiple national and international research projects, she continues to explore the frontiers of medical diagnostics, aiming to improve individualized patient care through cutting-edge biostatistical and biochemical methodologies πŸ”¬. Her research portfolio reflects a multidisciplinary approach, integrating pharmaceutical sciences with clinical applications for psychiatric conditions like schizophrenia.

Awards and HonorsπŸ†

Dr. Wirginia KrzyΕ›ciak has received numerous prestigious awards and honors throughout her career 🌟. In 2024, she was awarded the Rector’s Award for Scientific Achievements, recognizing her outstanding contributions to the field of medical diagnostics. The previous year, she received the Bronze Medal for Long Service, acknowledging her decade-long dedication to academia πŸ…. She has also been recognized multiple times by the Faculty of Pharmacy at Jagiellonian University Medical College, receiving the Dean’s Award for Scientific Achievements in 2022. Earlier in her career, she earned the Badge of the Krakow branch of the Polish Society of Microbiologists in 2017. Dr. KrzyΕ›ciak’s accomplishments are a testament to her dedication to scientific research, mentorship, and academic leadership. Her continuous commitment to advancing medical diagnostics, especially in schizophrenia research, has earned her a strong reputation in the scientific community 🧬.

Conclusion:

Dr. Wirginia KrzyΕ›ciak is an outstanding candidate for the Women Researcher Award. Her extensive experience, significant contributions to schizophrenia research, and leadership roles within academia make her a strong contender. She has demonstrated scientific excellence, international collaboration, and research leadership. However, focusing more on initiatives supporting women in science and engaging more broadly with the public could enhance her profile for this specific award.

Publications top notedπŸ“œ
  • From Periphery Immunity to Central Domain Through Clinical Interview as a New Insight on Schizophrenia
    KrzyΕ›ciak, W., Szwajca, M., Śmierciak, N., Skalniak, A., Popiela, T.
    Scientific Reports (2024), 14(1), 5755
    πŸ”¬ Citations: 1
  • Association of Blood Metabolomics Biomarkers with Brain Metabolites and Patient-Reported Outcomes as a New Approach in Individualized Diagnosis of Schizophrenia
    KrzyΕ›ciak, W., Bystrowska, B., Karcz, P., Popiela, T., Pilecki, M.
    International Journal of Molecular Sciences (2024), 25(4), 2294
    🧠 Citations: 0
  • Modified Lactoperoxidase System as a Promising Anticaries Agent: In Vitro Studies on Streptococcus mutans Biofilms
    Magacz, M., Alatorre-SantamarΓ­a, S., KΔ™dziora, K., PamuΕ‚a, E., KrzyΕ›ciak, W.
    International Journal of Molecular Sciences (2023), 24(15), 12136
    🦷 Citations: 1
  • Benefits and Meaning of Lipids Profile in Relation to Oxidative Balance and Brain Morphology in Schizophrenia
    Śmierciak, N., KrzyΕ›ciak, W., Szwajca, M., Aleksandrovych, V., Pilecki, M.
    International Journal of Molecular Sciences (2023), 24(14), 11375
    🧬 Citations: 3
  • The Association of the Oral Microbiota with the Effects of Acid Stress Induced by an Increase of Brain Lactate in Schizophrenia Patients
    KrzyΕ›ciak, W., Karcz, P., Bystrowska, B., Popiela, T.J., Pilecki, M.
    Biomedicines (2023), 11(2), 240
    🧫 Citations: 4
  • Safety Assessment of the Modified Lactoperoxidase Systemβ€”In Vitro Studies on Human Gingival Fibroblasts
    Magacz, M., PapieΕΌ, M., KoΕ›cielniak, D., PamuΕ‚a, E., KrzyΕ›ciak, W.
    International Journal of Molecular Sciences (2023), 24(3), 2640
    πŸ§ͺ Citations: 2
  • Risk Factors for Weight Gain in Patients with First-Episode Psychosis
    Batko, B., Szwajca, M., Śmierciak, N., Turek, A., Pilecki, M.
    Psychiatria Polska (2023), 57(1), pp. 51–64
    πŸ‹οΈ Citations: 1
  • Immunological Routine Laboratory Parameters at Admission Influence the Improvement of Positive Symptoms in Schizophrenia Patients After Pharmacological Treatment
    Skalniak, A., KrzyΕ›ciak, W., Śmierciak, N., Kozicz, T., Pilecki, M.
    Frontiers in Psychiatry (2023), 14, 1082135
    πŸ’Š Citations: 4
  • Effect of a Short-Term Intervention with Lactobacillus salivarius Probiotic on Early Childhood Cariesβ€”An Open Label Randomized Controlled Trial
    Staszczyk, M., Jamka-Kasprzyk, M., KoΕ›cielniak, D., KrzyΕ›ciak, W., Jurczak, A.
    International Journal of Environmental Research and Public Health (2022), 19(19), 12447
    πŸ‘Ά Citations: 11

Kyu Min Kim | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Global Scholar Awards

Dr. Kyu Min Kim | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Associate Professor at Chosun University, South Korea

Dr. Kyu Min Kim, born on July 13, 1984, is an Associate Professor at the Laboratory of Translational Genetics, Department of Biomedical Science, College of Natural Science, Chosun University, Korea. He also holds a position as a registered pharmacist in the Republic of Korea. πŸ“…πŸ«

Professional profile

EducationπŸ“š

Dr. Kim completed his Ph.D. in Pharmacy with a focus on Molecular Pharmacology at Seoul National University (2011-2018), where he investigated antifibrotic targets in hepatic stellate cells. He obtained his M.S. in Pharmacy from Chosun University (2007-2009) and his B.S. in Pharmacy from the same institution (2003-2007). πŸŽ“πŸ“š

Professional ExperienceπŸ›οΈ

Dr. Kim has extensive experience in academia and research. He served as a Teaching and Research staff at Chosun University (Mar 2018 – Feb 2021) and as a researcher at several institutes, including the Research Institute of Pharmaceutical Science at Chosun University and Seoul National University. His career also includes experience as a pharmacist at Chonnam National University Hospital. πŸ₯πŸ”¬

Research Interest🌐

His research interests span molecular pharmacology, liver pathophysiology, and antifibrotic mechanisms. Dr. Kim focuses on hepatic stellate cell activation, liver fibrosis, and cellular responses to oxidative stress, aiming to understand and address complex biological and therapeutic challenges. πŸ”¬πŸ’‰

Awards and HonorsπŸ†

Dr. Kim has received several accolades for his work, including the Excellent Paper Award at the 2nd China Chemical Looping Conference (2023), recognition as an Outstanding Graduate Student in Shanghai (2022), and the National Scholarship of the People’s Republic of China (2021). These honors underscore his significant contributions to his field. πŸ†πŸŽ–οΈ

AchievementsπŸ…
  • Innovative Research Contributions:
    • Developed novel insights into hepatic stellate cell activation and antifibrotic targets, enhancing understanding of liver fibrosis mechanisms. πŸ”¬πŸ§¬
    • Investigated the role of sphingosine kinase in liver pathophysiology, providing a deeper comprehension of liver-related diseases. 🌟πŸ§ͺ
  • Academic and Research Excellence:
    • Awarded the Excellent Paper of the 2nd China Chemical Looping Conference (2023). πŸ…πŸ”¬
    • Recognized as an Outstanding Graduate Student in Shanghai (2022). πŸ†πŸŽ“
    • Received the National Scholarship of the People’s Republic of China (2021). πŸŽ–οΈπŸŒ
  • Professional Impact:
    • Significant contributions to molecular pharmacology through various research roles at Chosun University and Seoul National University. πŸ’ΌπŸ₯
    • Actively involved in advancing pharmacological research and education in his field. πŸ“ˆπŸ‘¨β€πŸ«
Publications top notedπŸ“œ
  • Parkin-Mediated Mitophagy by TGF-Ξ² Is Connected with Hepatic Stellate Cell Activation
    • Authors: Lee, J.H., Kim, K.M.*, Jung, E.H., Cho, S.S., Ki, S.H.
    • Journal: International Journal of Molecular Sciences
    • Year: 2023
    • Citations: 2 πŸ“„πŸ”¬
  • Integrative Roles of Sphingosine Kinase in Liver Pathophysiology
    • Authors: Kim, K.M.*, Shin, E.J., Yang, J.H., Ki, S.H.
    • Journal: Toxicological Research
    • Year: 2023
    • Citations: 4 πŸ§¬πŸ”
  • Identification of Histone Lysine Acetoacetylation as a Dynamic Post-Translational Modification Regulated by HBO1
    • Authors: Gao, Y., Sheng, X., Tan, D., Zhao, Y., Lee, S., Kim, K.M
    • Journal: Advanced Science
    • Year: 2023
    • Citations: 2 πŸ“šβœ¨
  • Protective Effect of Castanopsis sieboldii Extract against UVB-Induced Photodamage in Keratinocytes
    • Authors: Lee, H.R., Yang, J.H., Lee, J.H., Kim, K.M., Shin, H.-J., Ki, S.H.
    • Journal: Molecules
    • Year: 2023
    • Citations: 3 πŸŒΏπŸ›‘οΈ
  • Ferroptosis Contributes to Hepatic Stellate Cell Activation and Liver Fibrogenesis
    • Authors: Cho, S.S., Yang, J.H., Lee, J.H., Kim, K.M*, Ki, S.H.
    • Journal: Free Radical Biology and Medicine
    • Year: 2022
    • Citations: 15 🩸⚠️
  • Regulated in Development and DNA Damage Response 1 Protects Hepatocytes Against Palmitate-Induced Lipotoxicity
    • Authors: Kim, J.H., Kim, K.M*, Yang, J.H., Lee, J.H., Ki, S.H.
    • Journal: Biotechnology and Bioprocess Engineering
    • Year: 2022
    • Citations: 0 πŸ›‘οΈπŸ”¬
  • Characterization of Hyperglycemia Due to Sub-Chronic Administration of Red Ginseng Extract via Comparative Global Proteomic Analysis
    • Authors: Na, A.-Y., Jo, J.J., Kwon, O.K., Kim, J.H., Kim, K.M, Ki, S.H., Lee, S.
    • Journal: Scientific Reports
    • Year: 2021
    • Citations: 3 πŸŒ±πŸ”¬
  • REDD1 Attenuates Hepatic Stellate Cell Activation and Liver Fibrosis via Inhibiting the TGF-Ξ²/Smad Signaling Pathway
    • Authors: Cho, S.S., Lee, J.H., Kim, K.M*, Yang, J.H., Ki, S.H.
    • Journal: Free Radical Biology and Medicine
    • Year: 2021
    • Citations: 21 πŸŒŸπŸ’‘
  • Circulating Small Extracellular Vesicles Activate TYRO3 to Drive Cancer Metastasis and Chemoresistance
    • Authors: Park, M., Kim, J.W., Kim, K.M*, Cho, Y., Lee, H., Baek, M.C., et al.
    • Journal: Cancer Research
    • Year: 2021
    • Citations: 13 πŸ¦ πŸš€
  • Transforming Growth Factor Beta-Induced FoxO3a Acts as a Profibrotic Mediator in Hepatic Stellate Cells
    • Authors: Kim, S.J., Kim, K.M*, Yang, J.H., Park, E.Y., Ki, S.H.
    • Journal: Toxicological Sciences
    • Year: 2021
    • Citations: 4 πŸ”¬πŸ”„

Shaobo Ruan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Global Scholar Awards

Prof. Shaobo Ruan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Associate Professor of Beijing Institute of Technology, China

Prof. Shaobo Ruan 🌟 is a distinguished academic with a focus on Pharmaceutics and Bioengineering. He earned his Ph.D. and M.D. in Pharmaceutics from the West China School of Pharmacy, Sichuan University πŸŽ“, where he was mentored by Professors Huile Gao and Qin He. He also holds a B.S. in Pharmaceutics from Wannan Medical College. Prof. Ruan’s career includes significant roles as an Associate Professor at the Advanced Research Institute of Multidisciplinary Science πŸ›οΈ, Beijing Institute of Technology, and as a Postdoctoral Associate at the University of Florida and the University of Kansas πŸ”¬. His research and academic pursuits have made notable contributions to the field of Pharmaceutics and Bioengineering, emphasizing interdisciplinary approaches and advanced scientific inquiry.

Professional profile

EducationπŸ“š

Prof. Shaobo Ruan πŸŽ“ has an impressive educational background in Pharmaceutics. He completed his Ph.D. in Pharmaceutics at West China School of Pharmacy, Sichuan University (2015-2018) 🏫, under the guidance of Professors Huile Gao and Qin He. Prior to that, he earned his M.D. in Pharmaceutics from the same institution (2012-2015) πŸ₯. His foundational studies were completed with a B.S. in Pharmaceutics from Wannan Medical College (2008-2012) πŸŽ“.

Professional ExperienceπŸ›οΈ

Prof. Shaobo Ruan 🌟 has built a notable career in the field of Pharmaceutics and Bioengineering. He is currently serving as an Associate Professor at the Advanced Research Institute of Multidisciplinary Science, Beijing Institute of Technology πŸ›οΈ since September 2021. Previously, he was a Postdoctoral Associate in Pharmaceutics at the University of Florida πŸŽ“ from July 2020 to July 2021. He also held a Postdoctoral Associate position in Bioengineering at the University of Kansas πŸ”¬ from July 2018 to June 2021. His roles have significantly contributed to advancements in his field, integrating research and interdisciplinary approaches.

Research Interest🌐

Prof. Shaobo Ruan πŸ”¬ is deeply engaged in research that bridges Pharmaceutics and Bioengineering. His interests focus on the development and optimization of pharmaceutical formulations, drug delivery systems, and bioengineering applications 🌟. Prof. Ruan explores innovative methods to enhance drug efficacy and safety, integrating advanced technologies and interdisciplinary approaches to address complex challenges in the field. His work aims to advance therapeutic solutions and improve patient outcomes, making significant contributions to both scientific research and practical applications in Pharmaceutics and Bioengineering.

Awards and HonorsπŸ†

Prof. Shaobo Ruan 🌟 has received notable recognition for his contributions to Pharmaceutics and Bioengineering. His excellence in research and academic achievements have earned him prestigious awards and honors πŸ…. These accolades reflect his significant impact on the field, highlighting his dedication to advancing pharmaceutical sciences and bioengineering innovations. Prof. Ruan’s commitment to research and education continues to be acknowledged through various awards, underscoring his role as a leading figure in his discipline. πŸ†βœ¨

AchievementsπŸ…
  • Ph.D. in Pharmaceutics from West China School of Pharmacy, Sichuan University πŸŽ“
  • M.D. in Pharmaceutics from West China School of Pharmacy, Sichuan University πŸ₯
  • B.S. in Pharmaceutics from Wannan Medical College πŸŽ“
  • Associate Professor at the Advanced Research Institute of Multidisciplinary Science, Beijing Institute of Technology πŸ›οΈ
  • Postdoctoral Associate at the University of Florida and University of Kansas πŸ”¬
  • Advanced pharmaceutical formulations and drug delivery systems 🌟
  • Notable contributions to Bioengineering and interdisciplinary research ✨
  • Recognition through prestigious awards and honors πŸ†
ProjectsπŸ› οΈ
  • Development of Advanced Drug Delivery Systems πŸ’‰: Innovating methods to enhance the efficacy and safety of pharmaceutical formulations.
  • Optimization of Pharmaceutical Formulations πŸ’Š: Improving drug stability, release profiles, and therapeutic outcomes.
  • Bioengineering Applications in Pharmaceutics 🌟: Integrating bioengineering techniques to address complex pharmaceutical challenges.
  • Interdisciplinary Research Initiatives πŸ”: Collaborating across fields to advance research in Pharmaceutics and Bioengineering.
  • Innovative Drug-Device Combination Products πŸ’‘: Designing and evaluating novel drug delivery systems that combine pharmaceuticals with medical devices.
Publications top notedπŸ“œ
  • Self-targeting fluorescent carbon dots for diagnosis of brain cancer cells
    πŸ“„ Authors: M Zheng, S Ruan, S Liu, T Sun, D Qu, H Zhao, Z Xie, H Gao, X Jing, Z Sun
    πŸ† Journal: ACS Nano
    πŸ“… Year: 2015
    πŸ” Citations: 504
  • Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles
    πŸ“„ Authors: S Ruan, M Yuan, L Zhang, G Hu, J Chen, X Cun, Q Zhang, Y Yang, Q He, …
    πŸ† Journal: Biomaterials
    πŸ“… Year: 2015
    πŸ” Citations: 365
  • Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release
    πŸ“„ Authors: S Ruan, X Cao, X Cun, G Hu, Y Zhou, Y Zhang, L Lu, Q He, H Gao
    πŸ† Journal: Biomaterials
    πŸ“… Year: 2015
    πŸ” Citations: 280
  • Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment
    πŸ“„ Authors: R Liu, C Luo, Z Pang, J Zhang, S Ruan, M Wu, L Wang, T Sun, N Li, L Han, …
    πŸ† Journal: Chinese Chemical Letters
    πŸ“… Year: 2023
    πŸ” Citations: 271
  • Enzyme-triggered size shrink and laser-enhanced NO release nanoparticles for deep tumor penetration and combination therapy
    πŸ“„ Authors: C Hu, X Cun, S Ruan, R Liu, W Xiao, X Yang, Y Yang, C Yang, H Gao
    πŸ† Journal: Biomaterials
    πŸ“… Year: 2018
    πŸ” Citations: 248
  • Increased Gold Nanoparticle Retention in Brain Tumors by in Situ Enzyme-Induced Aggregation
    πŸ“„ Authors: S Ruan, C Hu, X Tang, X Cun, W Xiao, K Shi, Q He, H Gao
    πŸ† Journal: ACS Nano
    πŸ“… Year: 2016
    πŸ” Citations: 243
  • Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma
    πŸ“„ Authors: S Ruan, Q He, H Gao
    πŸ† Journal: Nanoscale
    πŸ“… Year: 2015
    πŸ” Citations: 174
  • Aggregable nanoparticles-enabled chemotherapy and autophagy inhibition combined with anti-PD-L1 antibody for improved glioma treatment
    πŸ“„ Authors: S Ruan, R Xie, L Qin, M Yu, W Xiao, C Hu, W Yu, Z Qian, L Ouyang, Q He, …
    πŸ† Journal: Nano Letters
    πŸ“… Year: 2019
    πŸ” Citations: 151
  • A novel strategy through combining iRGD peptide with tumor-microenvironment-responsive and multistage nanoparticles for deep tumor penetration
    πŸ“„ Authors: X Cun, J Chen, S Ruan, L Zhang, J Wan, Q He, H Gao
    πŸ† Journal: ACS Applied Materials & Interfaces
    πŸ“… Year: 2015
    πŸ” Citations: 136
  • Acid‐responsive transferrin dissociation and GLUT mediated exocytosis for increased blood–brain barrier transcytosis and programmed glioma targeting delivery
    πŸ“„ Authors: S Ruan, L Qin, W Xiao, C Hu, Y Zhou, R Wang, X Sun, W Yu, Q He, H Gao
    πŸ† Journal: Advanced Functional Materials
    πŸ“… Year: 2018
    πŸ” Citations: 131
  • Rethinking CRITID procedure of brain targeting drug delivery: circulation, blood brain barrier recognition, intracellular transport, diseased cell targeting, internalization
    πŸ“„ Authors: S Ruan, Y Zhou, X Jiang, H Gao
    πŸ† Journal: Advanced Science
    πŸ“… Year: 2021
    πŸ” Citations: 120
  • A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan
    πŸ“„ Authors: X Cun, S Ruan, J Chen, L Zhang, J Li, Q He, H Gao
    πŸ† Journal: Acta Biomaterialia
    πŸ“… Year: 2016
    πŸ” Citations: 118
  • A simple one-step method to prepare fluorescent carbon dots and their potential application in non-invasive glioma imaging
    πŸ“„ Authors: S Ruan, J Qian, S Shen, J Zhu, X Jiang, Q He, H Gao
    πŸ† Journal: Nanoscale
    πŸ“… Year: 2014
    πŸ” Citations: 116